Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers
Abstract
Morreton virus (MORV) is an oncolytic Vesiculovirus, genetically distinct from vesicular stomatitis virus (VSV).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 11, 2022
- Source ID
- 10.1002/hep.32769
Entities
People
- Alexander T. Baker
- Alexei Basnakian
- Bertram Jacobs
- Bolni Marius Nagalo
- Camila C. Simoes
- Chelsae Dumbauld
- Dan G Duda
- Elizabeth Raupach
- Emilien J. Loeuillard
- Faaiq Aslam
- James M. Bogenberger
- Jean Christopher Chamcheu
- Joachim Petit
- Kenneth Buetow
- Lewis R. Roberts
- Mansi Arora
- Martin J. Cannon
- Michael A Barry
- Michael T. Barrett
- Mitesh J. Borad
- Musa Gabere
- Natalie Elliott
- Nathalie Meurice
- Oumar Barro
- Pedro Luiz Serrano Usón
- Richard Vile
- Steven R. Post
- Sumera I. Ilyas
- Yumei Zhou
Organizations
- Albert Einstein Israelite Hospital
- Arizona State University
- Harvard Medical School
- Mayo Clinic
- University of Arkansas for Medical Sciences